ARISTEIA CAPITAL, L.L.C. - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOTW and the CUSIP is G1125A116. A total of 1 filers reported holding BIOTECH ACQUISITION COMPANY in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ARISTEIA CAPITAL, L.L.C. ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$37,360
+9.9%
601,1330.0%0.00%0.0%
Q3 2022$34,000
-12.8%
601,1330.0%0.00%0.0%
Q2 2022$39,000
-84.5%
601,133
-43.3%
0.00%
-80.0%
Q1 2022$251,000
-62.4%
1,060,104
-0.0%
0.01%
-58.3%
Q4 2021$668,0001,060,5040.01%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q1 2023
NameSharesValueWeighting ↓
Kingstown Capital 300,000$18,0000.06%
Radcliffe Capital Management, L.P. 202,950$2,014,0000.05%
RAMIUS ADVISORS LLC 567,986$34,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 63,832$633,0000.02%
MARSHALL WACE, LLP 575,000$5,709,0000.01%
Telemetry Investments, L.L.C. 153,694$9,0000.01%
Q Global Advisors, LLC 300,000$15,0000.01%
LMR Partners LLP 50,000$496,0000.01%
Segantii Capital Management Ltd 25,000$248,0000.01%
Corbin Capital Partners, L.P. 464,062$28,0000.01%
View complete list of BIOTECH ACQUISITION COMPANY shareholders